Trump's tariffs are meant to promote investment in domestic manufacturing, but experts told Scripps News the reality of ...

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...

Sanofi plans to invest $20 billion in U.S.-based drug R&D and manufacturing over five years, creating jobs and boosting ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

A new manufacturing plant in De Soto will be a Center of Excellence for the global company, along with expanded R&D ...

Merck is expanding domestic manufacturing with a $895 million investment in its Kansas factory, one of several major projects ...

The capital expansion includes an investment of $860 million in the site's existing manufacturing facility and a further $35 ...

Gilead Sciences announced $11 billion in new planned investment in the U.S. to boost its domestic manufacturing and research ...

(Reuters) -Gilead Sciences announced $11 billion in new planned investment in the U.S. to add to its domestic manufacturing ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher Boerner.

The Food and Drug Administration should look for ways to streamline regulations on new U.S. drug manufacturing facilities to ...